FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

766286008: Salicylic acid+boric acid 3%/5% conventional release cutaneous powder (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3661331019 Salicylic acid+boric acid 3%/5% conventional release cutaneous powder (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3661332014 Compound salicylic acid powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3661333016 Salicylic acid+boric acid 3%/5% conventional release cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3661331019 Salicylic acid+boric acid 3%/5% conventional release cutaneous powder (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3661332014 Compound salicylic acid powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3661333016 Salicylic acid+boric acid 3%/5% conventional release cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Salicylic acid+boric acid 3%/5% conventional release cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Boric acid false Inferred relationship Existential restriction modifier (core metadata concept)
    Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Has manufactured dose form Cutaneous powder false Inferred relationship Existential restriction modifier (core metadata concept)
    Salicylic acid+boric acid 3%/5% conventional release cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salicylic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Is a Product containing boric acid in topical dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
    Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Is a Product containing salicylic acid in topical dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
    Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start